Oura is heading for Wall Street, but the wearable health tech market is not waiting around to celebrate. As the Finnish smart ring pioneer moves toward a public offering — Oura’s IPO filing revealed annual revenue has surpassed $500 million — a pack of well-funded challengers is accelerating hard, each betting that the smart ring category is big enough to support more than one dominant player.
According to a TechCrunch report, companies including Ultrahuman, RingConn, and Evie Ring are sharpening their hardware, expanding their sensor suites, and chasing the same health-conscious consumers Oura spent years cultivating. The timing is pointed: Oura’s IPO roadshow will unfold against a backdrop of genuine competitive pressure, not just hypothetical future rivalry.
Qualcomm Money and Bigger Ambitions
The most significant sign that Oura’s competitors are playing long ball came just days before the IPO coverage: Qualcomm led a $70 million funding round into Ultrahuman, the Bangalore-founded ring maker that has positioned itself as the performance-first alternative to Oura’s wellness-focused brand. The thesis behind the investment, detailed in Qualcomm’s Ultrahuman bet, is that smart rings don’t have to stay passive sensors — they can become edge-computing devices capable of on-device AI processing, reducing dependence on cloud inference and enabling faster, more private health insights.
That is a meaningful hardware leap. Current smart rings, including Oura’s Gen 4, are primarily data-collection endpoints that offload processing to smartphones and cloud servers. If Ultrahuman can embed meaningful compute into a ring form factor — enabled by Qualcomm’s chip expertise — it would change the category’s value proposition entirely, not just for fitness tracking but potentially for continuous medical monitoring. That is a market worth chasing. Global wearable health tech is on a trajectory that makes the current smart ring segment look like early innings.
The Field Is Getting Crowded Fast
Ultrahuman is not the only name in the mix. RingConn, a Chinese hardware maker, has been undercutting competitors on price while quietly building out its sensor array, offering features like sleep apnea detection and continuous heart rate variability tracking at a price point well below Oura’s $349 entry-level ring. Evie Ring, meanwhile, has carved out a lane targeting women’s health with menstrual cycle tracking and body temperature monitoring baked into its core product experience — a demographic and use-case Oura has historically treated as secondary.
The broader competitive pressure matters for how investors should read Oura’s IPO. Strong revenue growth and a loyal subscriber base are real assets, but the moat is narrowing. Hardware differentiation in rings is constrained by physics — there is only so much sensor real estate on a finger. The battle is increasingly shifting to software intelligence, health algorithm accuracy, and the stickiness of subscription ecosystems. Oura charges a $5.99 monthly fee for its full analytics suite, a model that rivals are beginning to copy or challenge with one-time-purchase data access. The companies now circling Oura understand that the ring itself is almost a Trojan horse — what matters is the platform that sits behind it.
The smart ring space is maturing fast, and Oura’s IPO will serve as a real-time stress test of whether the category’s pioneer can hold the line. For context, the dynamics here rhyme with patterns seen across other fast-scaling tech verticals — comparable to how AI infrastructure companies face a wave of challengers the moment a market leader signals confidence by going public. Being first to IPO is a milestone. Staying first in market share is a different kind of race entirely.
